Alfuzosin hydrochloride
- Product NDC
- 51655-967
- 11-digit product format
- 516550967
- Labeler code
- 51655
- Product ID
- 51655-967_4974b10e-b8f0-5aa8-e063-6294a90acd65
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA203192
- Marketing category
- ANDA
- Marketing start
- 2023-06-29
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alfuzosin hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALFUZOSIN HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 75046A1XTN |
| Rxcui | 861132 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-967-52 | Alfuzosin hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-967 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [NORTHWIND PHARMACEUTICALS, LLC] | 1 | Current NDC, 1 package rows | 20230707_ffbd22eb-9df5-e0ad-e053-6294a90a7d4e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 51655-967-52 | 51655096752 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-967-52) | 2023-06-29 | No | No | Historical |